Current readings: Blood-based biomarkers for lung cancer

Seminars in Thoracic and Cardiovascular Surgery

Volumn 25, Issue 4, 2013, Pages 328-334

  Tsay, Jun Chieh J ^a   DeCotiis, Christopher ^a   Greenberg, Alissa K ^a   Rom, William N ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autoantibodies; Biomarkers; Early diagnosis; Genomics; Lung cancer; MicroRNA; Proteomics

Indexed keywords

APTAMER; AUTOANTIBODY; DNA; NUCLEAR MATRIX PROTEIN; PROTEIN CIZ1; TUMOR MARKER; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; DNA DETERMINATION; EARLY DIAGNOSIS; GENE EXPRESSION; HUMAN; LUNG CANCER; LUNG NODULE; LUNG NON SMALL CELL CANCER; PATIENT CARE; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PROTEOMICS; QUANTITATIVE ANALYSIS;

EID: 84896452244     PISSN: 10430679     EISSN: 15329488     Source Type: Journal    
DOI: 10.1053/j.semtcvs.2013.11.001     Document Type: Article

References (20)

1. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006, 355(17):1763-1771. The International Early Lung Cancer Action Program Investigators.
2. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011, 365(5):395-409. Team* TNLSTR.
3. Greenberg A.K., Lu F., Goldberg J.D., et al. CT scan screening for lung cancer: Risk factors for nodules and malignancy in a high-risk urban cohort. PloS One 2012, 7(7):e39403.
4. Gold L., Ayers D., Bertino J., et al. Aptamer-based multiplexed proteomic technology for biomarker discovery. PloS One 2010, 5(12):e15004.
5. Ostroff R.M., Bigbee W.L., Franklin W., et al. Unlocking biomarker discovery: Large scale application of aptamer proteomic technology for early detection of lung cancer. PloS One 2010, 5(12):e15003.
6. Patz E.F., Campa M.J., Gottlin E.B., et al. Biomarkers to help guide management of patients with pulmonary nodules. Am J Respir Crit Care Med 2013, 188(4):461-465.
7. Higgins G., Roper K.M., Watson I.J., et al. Variant Ciz1 is a circulating biomarker for early-stage lung cancer. Proc Natl Acad Sci U S A 2012, 109(45):E3128-E3135.
8. Chapman C.J., Murray A., McElveen J.E., et al. Autoantibodies in lung cancer: Possibilities for early detection and subsequent cure. Thorax 2008, 63(3):228-233.
9. Boyle P., Chapman C.J., Holdenrieder S., et al. Clinical validation of an autoantibody test for lung cancer. Ann Oncol 2011, 22(2):383-389.
10. Lam S., Boyle P., Healey G.F., et al. EarlyCDT-lung: An immunobiomarker test as an aid to early detection of lung cancer. Cancer Prev Res (Phila) 2011, 4(7):1126-1134.
11. Ostrow K.L., Hoque M.O., Loyo M., et al. Molecular analysis of plasma DNA for the early detection of lung cancer by quantitative methylation-specific PCR. Clin Cancer Res 2010, 16(13):3463-3472.
12. Bartel D.P. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004, 116(2):281-297.
13. Boeri M., Verri C., Conte D., et al. MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc Natl Acad Sci U S A 2011, 108(9):3713-3718.
14. Showe M.K., Vachani A., Kossenkov A.V., et al. Gene expression profiles in peripheral blood mononuclear cells can distinguish patients with non-small cell lung cancer from patients with nonmalignant lung disease. Cancer Res 2009, 69(24):9202-9210.
15. U.S. PSTF: Lung Cancer Screening, Topic Page. Available at:. http://wwwuspreventiveservicestaskforceorg/uspstf/uspslunghtm.
16. Li X., Hayward C., Fong P.Y., et al. A Systems Biology-Derived, Blood-Based Proteomic Classifier for the Molecular Characterization of Pulmonary Nodules. Science Translational Medicine 2013, 5:207ra142.
17. Rom W., Goldberg J., Addrizzo-Harris D., et al. Identification of an autoantibody panel to separate lung cancer from smokers and nonsmokers. BMC Cancer 2010, 10(1):234.
18. Huang W., Hu J., Yang D.W., et al. Two microRNA panels to discriminate three subtypes of lung carcinoma in bronchial brushing specimens. Am J Respir Crit Care Med 2012, 186(11):1160-1167.
19. Lu Y., Govindan R., Wang L., et al. MicroRNA profiling and prediction of recurrence/relapse-free survival in stage I lung cancer. Carcinogenesis 2012, 33(5):1046-1054.
20. McWilliams A., Tammemagi M.C., Mayo J.R., et al. Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med 2013, 369(10):910-919.